Senior insider sale
Chief Operating Officer at PALVELLA THERAPEUTICS, INC. — senior position signals high conviction
$2.14M
17.21K shares
What this filing means
GOIN KATHLEEN plans to sell 17.21K shares of PALVELLA THERAPEUTICS, INC. valued at approximately $2.14M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/15/2026ACC: 0001967940-26-000039
Officer· Chief Operating Officer
Since Feb 2026
17.21K
Shares to sell
$2.14M
Approx. market value
4.30K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
7/15/2026
4.30KTotal acquired4.30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/15/2026 | Stock Option Exercise Cash | 4.30K | — |
| Total | 4.30K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
4.30K
Market value
$476.4K
6/17/2026
—Completed
Units to sell
4.30K
Market value
$475.6K
5/20/2026
—Completed
Units to sell
4.30K
Market value
$547.4K
4/15/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
4.30K
Market value
$643.9K
7/15/2026
Total
Units
17.21K
Value
$2.14M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/17/2026 | 4.30K | $476.4K | — | Completed |
5/20/2026 | 4.30K | $475.6K | — | Completed |
4/15/2026 | 4.30K | $547.4K | — | Completed |
| Planned — Approximate Date | ||||
7/15/2026 | 4.30K | $643.9K | Nasdaq | Planned |
| Total | 17.21K | $2.14M | ||